Alerts will be sent to your verified email
Verify Email
AMERISE
|
Amerise Biosciences
|
KLG Capital Services
|
Aravali Sec. & Fin
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-0.9 % | -0.25 % | 205.54 % |
|
5yr average Equity Multiplier
|
1.27 | 1.6 | 2.16 |
|
5yr Average Asset Turnover Ratio
|
0.15 | 0.06 | 0.12 |
|
5yr Avg Net Profit Margin
|
1.22 % | -2.47 % | -365.4 % |
|
Price to Book
|
1.13 | 0.79 | 0.0 |
|
P/E
|
0.0 | 86.82 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 0.0 | 0.0 |
|
Inventory Days
|
0.0 | 0.0 | 0.0 |
|
Days Receivable
|
0.0 | 0.0 | 0.0 |
|
Days Payable
|
275.57 Days | 0.0 | 0.0 |
|
5yr Average Interest Coverage Ratio
|
-475.34 | 14.95 | 2.53 |
|
5yr Avg ROCE
|
-0.92 % | -0.16 % | 438.9 % |
|
5yr Avg Operating Profit Margin
|
-0.04 % | -4.36 % | -1070.25 % |
|
5 yr average Debt to Equity
|
0.01 | 0.09 | -0.25 |
|
5yr CAGR Net Profit
|
0.0 | 5.92 % | n/a |
|
5yr Average Return on Assets
|
-1.74 % | -0.17 % | 12.57 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 60.46 % | 54.56 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 4.99 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Amerise Biosciences
|
KLG Capital Services
|
Aravali Sec. & Fin
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|